Protera Biosciences

Private

ParisHealthcare & Life Scienceshttps://www.proterabio.com/

Last Round

Series A

Jul 28, 2021

Total Funding Raised

$15.6M

Company Overview

Protera Biosciences is a biotechnology company that utilizes an AI-driven platform, madi™, to engineer and design new proteins for various applications, including food, agriculture, and human health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Infrastructure

Keywords

computational biologyprotein engineeringsynthetic biologyfood technologyclean-label ingredientsprecision fermentationprotein designgenerative AIfood techshelf-life extensionplant-based ingredientsSaaSdeep learningalternative proteinsbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Protera Biosciences Comps

Public and private peers based on sector, stage, and business model.

Protera Biosciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Protera Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jul 28, 2021
Series A	Jun 9, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Francia Navarrete Utreras

COO And Co-Founder

Founding Team

Franck Leyze

Chief Executive Officer

Executive Team

Leonardo Alvarez

CEO Founder

Founding Team

Protera Biosciences Investors

Notable investors and investment history

Protera Biosciences investors
Investor	Rounds
ICL Planet Startup Hub	Series A
Grupo Bimbo	Series A
IndieBio	Accelerator
Sofinnova Partners	Series A
SOSV	Series A

View all Investors

Protera Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Protera Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Protera Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis

Employee Range13

Year Founded2015

Last FundingJul 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.